Ginsenoside Rg3 in combination with artesunate overcomes sorafenib resistance in hepatoma cell and mouse models-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ginsenoside Rg3 in combination with artesunate overcomes sorafenib resistance in hepatoma cell and mouse models

Published:2021-07 Issue: Volume: Page:
ISSN:1226-8453
Container-title:Journal of Ginseng Research
language:en
Short-container-title:Journal of Ginseng Research

Author:

Chen Ying-Jie,Wu Jia-Ying,Deng Yu-Yi,Wu Ying,Wang Xiao-Qi,Li Amy Sze-man^ORCID,Wong Lut Yi,Fu Xiu-Qiong,Yu Zhi-Ling,Liang Chun

Funder

Guangzhou Municipal Science and Technology Project

Guangzhou Science Technology and Innovation Commission

Shenzhen Science and Technology Innovation Commission

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Biochemistry, Genetics and Molecular Biology (miscellaneous),Biotechnology

Reference45 articles.

1. Hepatocellular carcinoma;Llovet;Nat Rev Dis Prim,2016

2. Hepatocellular carcinoma;Llovet;Nat Rev Dis Prim,2021

3. Cost-effectiveness of atezolizumab plus bevacizumab vs sorafenib as first-line treatment of unresectable hepatocellular carcinoma;Su;JAMA Netw Open,2021

4. Sorafenib resistance in hepatocellular carcinoma: the relevance of genetic heterogeneity;Cabral;Cancers (Basel),2020

5. Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells;Zhao;Cell Signal,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ginseng extract (Ginsenoside RG3) combined with STING agonist reverses TAM/M2 polarization to inhibit TNBC evolution;Industrial Crops and Products;2024-12

2. Ethanol extract of lymphanax with gypenoside 17 and ginsenoside Re exerts anti-inflammatory properties by targeting the AKT/NF-κB pathway;Journal of Ginseng Research;2024-08

3. A novel selenium nanocomposite modified by AANL inhibits tumor growth by upregulating CLK2 in lung cancer;Bioorganic Chemistry;2024-07

4. Unveiling the experimental proof of the anticancer potential of ginsenoside Rg3 (Review);Oncology Letters;2024-02-28

5. Tanreqing injection inhibits stemness and enhances sensitivity of non-small cell lung cancer models to gefitinib through ROS/STAT3 signaling pathway;Journal of Cancer;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3